BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30287243)

  • 1. ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
    Nastały P; Filipska M; Morrissey C; Eltze E; Semjonow A; Brandt B; Pantel K; Bednarz-Knoll N
    Transl Res; 2019 Jan; 203():49-56. PubMed ID: 30287243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancer.
    Omari A; Nastały P; Stoupiec S; Bałabas A; Dąbrowska M; Bielińska B; Huss S; Pantel K; Semjonow A; Eltze E; Brandt B; Bednarz-Knoll N
    Int J Cancer; 2019 Feb; 144(3):607-614. PubMed ID: 30265376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
    Bednarz-Knoll N; Nastały P; Żaczek A; Stoupiec MG; Riethdorf S; Wikman H; Müller V; Skokowski J; Szade J; Sejda A; Wełnicka-Jaśkiewicz M; Pantel K
    Oncotarget; 2015 Sep; 6(29):26789-803. PubMed ID: 26305673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
    Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
    Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay.
    Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N
    J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data.
    Koh YW; Han JH; Haam S; Jung J
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1427-1436. PubMed ID: 30923946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
    Zhao Y; Jin X; Li N; Zhu B; Qian J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 47(1):54-9. PubMed ID: 27062782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
    Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
    Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors.
    Vogler T; Kriegl L; Horst D; Engel J; Sagebiel S; Schäffauer AJ; Kirchner T; Jung A
    Exp Mol Pathol; 2012 Feb; 92(1):111-7. PubMed ID: 22101256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
    Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
    Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of ALDH1, CXCR4 and E-cadherin in castric carcinoma and their roles in lymphatic metastasis].
    Zhao Y; Jin X; Li N; Li J; Qian J
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1390-1395. PubMed ID: 27777204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde dehydrogenase 1-positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node-positive breast cancer.
    Sakakibara M; Fujimori T; Miyoshi T; Nagashima T; Fujimoto H; Suzuki HT; Ohki Y; Fushimi K; Yokomizo J; Nakatani Y; Miyazaki M
    Cancer; 2012 Aug; 118(16):3899-910. PubMed ID: 22180194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWIST1 and SNAI1 as markers of poor prognosis in human colorectal cancer are associated with the expression of ALDH1 and TGF-β1.
    Kim YH; Kim G; Kwon CI; Kim JW; Park PW; Hahm KB
    Oncol Rep; 2014 Mar; 31(3):1380-8. PubMed ID: 24402192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasms.
    Guner G; Bishop JA; Bezerra SM; Taheri D; Zahavi DJ; Mendoza Rodriguez MA; Sharma R; Epstein JI; Netto GJ
    Hum Pathol; 2016 Aug; 54():184-8. PubMed ID: 27068523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
    Zenke Y; Ishii G; Ohe Y; Kaseda K; Yoshida T; Matsumoto S; Umemura S; Yoh K; Niho S; Goto K; Ohmatsu H; Kuwata T; Nagai K; Ochiai A
    Pathol Int; 2013 Dec; 63(12):599-606. PubMed ID: 24422956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Impact of ALDH1 Expression in Transitional Cell Carcinoma of the Renal Pelvis.
    Liu J; Jin J; Yang Y; Han W; Yu W; Shen C; Zhang N; Du P; Zhao Q; Wang S; Tang X
    Anticancer Res; 2015 Sep; 35(9):4829-36. PubMed ID: 26254374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status.
    Qian X; Wagner S; Ma C; Klussmann JP; Hummel M; Kaufmann AM; Albers AE
    Oncol Rep; 2013 May; 29(5):1777-84. PubMed ID: 23483187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.